Trade Summary
Ticker: CCXI (Last: $8.84)
Entry: $8.50-8.84
Price Target: $13-15.0+
Target Timeframe: 0-6 weeks
Trade Thesis
CCXI is an orphan/rare disease-focused company with a robust pipeline of clinical assets targeting autoimmune and inflammatory disorders as well as cancer. The company's lead asset CCX168 (Avacopan) is an orally administered small...